United Health Products Hemostyp® Gauze Included in Essential Preparedness Products Diabetic Emergency Kits

Colts Neck, NJ – February 14, 2012 – United Health Products, Inc.(OTCQB:UEEC), which develops and markets products and technologies in the healthcare sector, today announced that its hemostatic gauze (HemoStyp™) will be included in Diabetic Emergency Kits produced by Essential Preparedness Products - EPP. EPP's Diabetic Ecase ("Ecase") www.epp-ecase.com is designed to assist diabetics who face an emergency situation. They contain medications and products essential for life support and can be stored safely until needed. The Ecase is offered in two configurations to meet the various types of diabetic conditions that users may have. Diabetes is one of the fastest growing health concerns in the world with over 28 million diabetics in the US alone. EPP's Ecase will be available with numerous online pharmacies and emergency kit providers. EPP is also negotiating with several major retailers and pharmacies in the US and Canada to carry this product. EPP's website will post where the product is available to be purchased when the information is released. 

About United Health Products, Inc.
United Health Products, Inc. (UEEC) develops, manufactures, and markets a patent pending hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp™, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on ramping up sales in its current markets as well as identifying new markets and applications for its products and technologies. For more information on United Health Products, Inc. please visit: www.unitedhealthproductsinc.com.

Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:
United Health Products, Inc.
Dr. Phillip Forman, 732-239-3444
CEO